Covid vaccine: Pfizer withdraws Emergency Use Authorisation application in India

Pharma major Pfizer on Friday said it has decided to withdraw its application for Emergency Use Authorisation (EUA) of its Covid-19 vaccine in India.

Pfizer was the first pharmaceutical firm to seek an emergency use authorisation from the Drugs Controller General of India (DCGI) for its Covid-19 vaccine in the country, after it secured such clearance in the UK and Bahrain.

Pfizer will continue to engage with the authority and resubmit its approval request with additional information as it becomes available in the near future, the statement said.